Steven Cohen’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRA
Steven Cohen's ATRA Position: Q3 2026 in Review
Steven Cohen reduced its Atara Biotherapeutics (ATRA) stake by 1.5% in Q3 2026, selling an estimated $90.7K and leaving 677,696 shares worth $5.76M. The position accounts for 0.01% of the portfolio, ranked #1720.
Steven Cohen first reported a position in ATRA in Q1 2015 and has held it in 18 quarters since. The position peaked at $72.7M in Q4 2021. 36 funds tracked by Wall St. Rank hold ATRA as of Q3 2026.
- Steven Cohen held 677,696 shares of Atara Biotherapeutics worth $5.76M as of Q3 2026.
- Steven Cohen sold 10,022 Atara Biotherapeutics shares in Q3 2026, an estimated $90.7K.
- Atara Biotherapeutics made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1720 holding.
- Steven Cohen first reported a position in Atara Biotherapeutics in Q1 2015 and has held it in 18 quarters since.
- Steven Cohen's Atara Biotherapeutics position peaked at $72.7M in Q4 2021.
- 36 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.